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The effects of  vitamin D on the renin-angiotensin system 
In humans, 80-90% of  required vitamin D is made in the skin upon sun exposure and the remaining 10-20% is ingested in fish, 
eggs and fortified dairy products. In the liver, 
vitamins D2(ergocalciferol) and D3(cholecalcif-
erol) are converted into 25-hydroxyvitamin D2 
(25[OH]D2) and 25-hydroxyvitamin D3 (25(OH]
D3), respectively (1). In the kidney, 25(OH)D is 
converted to its biologically active form 1,25-di-
hydroxyvitamin D (1,25[OH]2D) by 1α-hydrox-
ylase. The serum level of  25(OH)D is used to 
determine vitamin D status and normally ranges 
between 30-100 ng/mL (75–250 nmol/L).  Vi-
tamin D insufficiency and deficiency are defined 
as serum 25(OH)D levels of  20-30 mg/dL (50-
75 nmol/L) and <20 ng/mL (50 nmol/L), re-
spectively (2).  The critical role of  1,25(OH)2D 
in calcium and phosphorus homeostasis is well 
established (1,2).  Accumulating evidence indi-
cates that vitamin D also plays an important role 
in regulating the blood pressure. 
A recent randomized, double-blind, placebo con-
trolled study conducted by Nasri et al. demonstrat-
ed that oral supplementation of  vitamin D led to a 
decrease in the blood pressure in individuals with 
diabetes mellitus (3).  Sixty individuals were ran-
domized to receive either vitamin D3 50,000 IU 
per week (n=30) or placebo (n=30) for 12 weeks. 
Five individuals (8.3%) had vitamin D deficiency 
and 27 others (45%) had vitamin D insufficien-
cy.  Vitamin D supplementation increased serum 
25(OH)D levels from 84±52 nmol/L to 164±57 
nmol/L (P= 0.001). Vitamin D supplementa-
tion led to a decrease in both systolic (121±13 
to 110±9 mm Hg; P= 0.001) and diastolic blood 
pressure (81±8 to 76±7 mm Hg, P= 0.046). No 
statistically significant change in blood pressure 
was observed in the placebo group.
The pivotal role of  the renin-angiotensin system 
in the regulation of  the blood pressure is well 
established (Figure 1). Renin is secreted by the 
juxtaglomerular cells of  the kidney in response 
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to decreased renal blood flow. It converts plas-
ma angiotensinogen to angiotensin I, which is 
then converted to angiotensin II by angioten-
sin-converting enzyme. Angiotensin II leads to 
increased water and sodium reabsorption in the 
kidney and vasoconstriction.  Mounting evi-
dence indicates that vitamin D regulates the re-
nin-angiotensin system. An inverse relationship 
between the blood pressure and serum 25(OH)
D levels has been documented in a number of 
the epidemiological studies (4,5).  In a cross-sec-
tional study, Forman et al. explored the relation 
between 25(OH)D and the renin-angiotensin sys-
tem in 184 individuals with normal blood pres-
sure (6).  Compared with vitamin D-sufficient 
individuals, those with vitamin D deficiency and 
insufficiency had greater plasma angiotensin II 
levels and a trend for higher plasma renin activity. 
In addition, the activity of  the renin-angiotensin 
system in the kidney, as measured by the renal 
plasma flow in response to angiotensin II infu-
sion, was greater in vitamin D-deficient than in 
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vitamin D-sufficient individuals.  These results 
suggested that decreased plasma 25(OH)D levels 
were associated with increased activity of  the re-
nin angiotensin system.  Resnick et al. investigat-
ed the relation between the plasma renin activity 
and calcium-regulating hormones including calci-
tonin, 1,25(OH)2D3 and parathyroid hormone in 
51 individuals with essential hypertension (7).  An 
inverse relation of  the serum 1,25(OH)2D3 level 
to the plasma renin activity (r= −0.65, P< 0.001) 
was observed. This study corroborated a link be-
tween calcium homeostasis, vitamin D metabo-
lism and the renin-angiotensin system.
To unravel the molecular mechanisms involved in 
vitamin D-mediated regulation of  the renin-an-
giotensin system, mice with loss-of-function mu-
tations involving vitamin D receptor gene (VDR-
null mice) were examined.  The VDR-null mice 
develop hypocalcemia at 3 weeks of  age, hyper-
parathyroidism, rickets and osteomalacia (8).  Li 
et al. demonstrated that renin gene expression in 
the kidney and angiotensin II levels in the plasma 
were substantially increased in the VDR-null mice 
leading to hypertension and cardiac hypertrophy 
(9).  In wild-type mice, pharmacological inhibi-
tion of  1,25(OH)2D3 synthesis led to an increase 
in renin gene expression, whereas 1,25(OH)2D3 
treatment suppressed renin expression. Similar-
ly, 1,25(OH)2D3 markedly suppressed renin gene 
expression in cultured cells by a VDR-mediated 
mechanism. These investigators also demonstrat-
ed that the effect of  vitamin D on renin gene 
expression was independent of  calcium metab-
olism. The authors concluded that 1,25(OH)2D3 
is a negative regulator of  the renin-angioten-
sin system. Subsequently, it was shown that 
1,25(OH)2D3 suppressed renin gene expression 
by binding to the transcription factor cAMP re-
sponse element-binding protein (CREB), thereby 
suppressing the activity of  the cAMP response 
element in the renin gene promoter (10).
To determine whether the inhibitory effects of 
1,25(OH)2D on the renin-angiotensin system is 
dependent on calcium or phosphorous, Zhou el 
al. examined the effects of  dietary interventions 
Figure 1. The effects of  vitamin D on the renin-angio-
tensin system. 1,25-dihydroxyvitamin D suppresses renin 
gene expression, thereby inhibiting the renin-angiotensin 
system. ACE, angiotensin-converting enzyme; H2O, water; 
Na, sodium.
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in 1α-hydroxylase knockout mice. Phenotypical-
ly resembling VDR-null mice, 1α-hydroxylase 
knockout mice demonstrate undetectable serum 
1,25(OH)2D levels and develop hypocalcemia, 
hypophosphatemia, secondary hyperparathy-
roidism, growth retardation and skeletal abnor-
malities characteristic of  rickets (11). Zhou et al. 
demonstrated that 1α-hydroxylase knockout mice 
developed hypertension and cardiac hypertrophy 
associated with the activation of  the renin-an-
giotensin system in the kidney and heart (12). 
Despite the normalization of  the serum calcium 
and phosphorus levels, a calcium- and phospho-
rus-fortified diet neither normalized  the blood 
pressure nor suppressed the activity of  the re-
nin-angiotensin system in the 1α-hydroxylase 
knockout mice.  However, 1,25(OH)2D treat-
ment led to the normalization of  the activity of 
the renin-angiotensin system and blood pressure.
In summary, the current literature indicates that 
maintaining adequate vitamin D levels may be an 
important consideration in the treatment of  hy-
pertension, especially in individuals with vitamin 
D insufficiency and deficiency.
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